MAPT and Alzheimer disease: Although Aβ has predominated AD research for the past 30 years [2], the recent emergence of positron emission tomography (PET) imaging of tau NFTs has allowed for in vivo characterization of this pathology and highlights the enduring importance of tau in the development and progression of AD [3].